Toll Free: 1-888-928-9744
Published: Sep, 2016 | Pages:
32 | Publisher: Global Markets Direct
Industry: Pharmaceuticals & Healthcare | Report Format: Electronic (PDF)
Sinovac Biotech Ltd. - Product Pipeline Review - 2016 Summary Global Markets Direct's, 'Sinovac Biotech Ltd. - Product Pipeline Review - 2016', provides an overview of the Sinovac Biotech Ltd.'s pharmaceutical research and development focus. The report provides comprehensive information on the therapeutics under development by Sinovac Biotech Ltd., complete with analysis by stage of development, drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. The report also covers the descriptive pharmacological action of the therapeutics, its complete research and development history and the dormant and discontinued projects. Global Markets Direct's report features investigational drugs from across globe covering over 20 therapy areas and nearly 3,000 indications. The report is built using data and information sourced from Global Markets Direct's proprietary databases, company/university websites, clinical trial registries, conferences, SEC filings, investor presentations and featured press releases from company/university sites and industry-specific third party sources. Drug profiles featured in the report undergoes periodic review following a stringent set of processes to ensure that all the profiles are updated with the latest set of information. Additionally, various dynamic tracking processes ensure that the most recent developments are captured on a real time basis. The report helps in identifying and tracking emerging players in the market and their portfolios, enhances decision making capabilities and helps to create effective counter strategies to gain competitive advantage. Note*: Certain sections in the report may be removed or altered based on the availability and relevance of data. Scope - The report provides a snapshot of the pipeline therapeutic landscape of Sinovac Biotech Ltd. - The report provides overview of Sinovac Biotech Ltd. including its business description, key facts, and locations and subsidiaries - The report features descriptive drug profiles for the pipeline products which includes, product description, descriptive MoA, R&D brief, licensing and collaboration details & other developmental activities - The report covers pipeline products based on various stages of development ranging from pre-registration till discovery and undisclosed stages - The report assesses Sinovac Biotech Ltd.'s pipeline therapeutics based on drug target, mechanism of action (MoA), route of administration (RoA) and molecule type - The report features Sinovac Biotech Ltd.'s out-licensed and partnered product portfolio and summarizes its dormant and discontinued projects Reasons To Buy - Evaluate Sinovac Biotech Ltd.'s strategic position with total access to detailed information on its product pipeline - Gain strategically significant competitor information, analysis, and insights to formulate effective R&D strategies - Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage - Identify and understand important and diverse types of therapeutics under development for Sinovac Biotech Ltd. - Identify potential new clients or partners in the target demographic - Plan mergers and acquisitions effectively by identifying key players and it's most promising pipeline therapeutics - Devise corrective measures for pipeline projects by understanding Sinovac Biotech Ltd.'s pipeline depth and focus of pipeline therapeutics - Develop and design in-licensing and out-licensing strategies by identifying prospective partners with the most attractive projects to enhance and expand business potential and scope
Table of Contents Table of Contents 2 List of Tables 4 List of Figures 4 Sinovac Biotech Ltd. Snapshot 5 Sinovac Biotech Ltd. Overview 5 Key Facts 5 Sinovac Biotech Ltd. - Research and Development Overview 6 Key Therapeutic Areas 6 Sinovac Biotech Ltd. - Pipeline Review 9 Pipeline Products by Stage of Development 9 Pipeline Products - Monotherapy 10 Pipeline Products - Combination Treatment Modalities 11 Pipeline Products - Partnered Products 12 Partnered Products/Combination Treatment Modalities 13 Sinovac Biotech Ltd. - Pipeline Products Glance 14 Sinovac Biotech Ltd. - Clinical Stage Pipeline Products 14 Phase I Products/Combination Treatment Modalities 14 Sinovac Biotech Ltd. - Early Stage Pipeline Products 15 IND/CTA Filed Products/Combination Treatment Modalities 15 Preclinical Products/Combination Treatment Modalities 16 Sinovac Biotech Ltd. - Drug Profiles 17 (measles + mumps + rubella) vaccine - Drug Profile 17 Product Description 17 Mechanism Of Action 17 R&D Progress 17 chickenpox vaccine - Drug Profile 18 Product Description 18 Mechanism Of Action 18 R&D Progress 18 coxsackievirus [serotype A16] vaccine - Drug Profile 19 Product Description 19 Mechanism Of Action 19 R&D Progress 19 diphtheria + pertussis(acellular) + tetanus vaccine - Drug Profile 20 Product Description 20 Mechanism Of Action 20 R&D Progress 20 haemophilus influenzae B vaccine - Drug Profile 21 Product Description 21 Mechanism Of Action 21 R&D Progress 21 hepatitis A + hepatitis B vaccine - Drug Profile 22 Product Description 22 Mechanism Of Action 22 R&D Progress 22 hepatitis B vaccine - Drug Profile 23 Product Description 23 Mechanism Of Action 23 R&D Progress 23 influenza [strain A/H7N9] vaccine - Drug Profile 24 Product Description 24 Mechanism Of Action 24 R&D Progress 24 polio vaccine - Drug Profile 25 Product Description 25 Mechanism Of Action 25 R&D Progress 25 rabies vaccine - Drug Profile 26 Product Description 26 Mechanism Of Action 26 R&D Progress 26 rotavirus vaccine - Drug Profile 27 Product Description 27 Mechanism Of Action 27 R&D Progress 27 Sinovac Biotech Ltd. - Pipeline Analysis 28 Sinovac Biotech Ltd. - Pipeline Products by Molecule Type 28 Sinovac Biotech Ltd. - Dormant Projects 29 Sinovac Biotech Ltd. - Locations And Subsidiaries 30 Head Office 30 Other Locations & Subsidiaries 30 Appendix 31 Methodology 31 Coverage 31 Secondary Research 31 Primary Research 31 Expert Panel Validation 31 Contact Us 31 Disclaimer 32
List of Tables Sinovac Biotech Ltd., Key Facts 5 Sinovac Biotech Ltd. - Pipeline by Indication, 2016 8 Sinovac Biotech Ltd. - Pipeline by Stage of Development, 2016 9 Sinovac Biotech Ltd. - Monotherapy Products in Pipeline, 2016 10 Sinovac Biotech Ltd. - Combination Treatment Modalities in Pipeline, 2016 11 Sinovac Biotech Ltd. - Partnered Products in Pipeline, 2016 12 Sinovac Biotech Ltd. - Partnered Products/ Combination Treatment Modalities, 2016 13 Sinovac Biotech Ltd. - Phase I, 2016 14 Sinovac Biotech Ltd. - IND/CTA Filed, 2016 15 Sinovac Biotech Ltd. - Preclinical, 2016 16 Sinovac Biotech Ltd. - Pipeline by Molecule Type, 2016 28 Sinovac Biotech Ltd. - Dormant Developmental Projects,2016 29 Sinovac Biotech Ltd., Subsidiaries 30
Speak to the report author to design an exclusive study to serve your research needs.
Your personal and confidential information is safe and secure.